发明名称 Aspartyl protease inhibitors
摘要 The present invention provides compounds having formula (I): wherein R', R<0>, R<1>, X<1>, R<2>, R<3>, R<3'>, X<2>, X<3 >and R<4 >are as defined herein, and pharmaceutical compositions thereof. The present invention also provides methods of inhibiting proteases, more specifically aspartyl proteases. In certain embodiments, compounds inhibit BACE (beta-site APP-cleaving enzyme), and thus are useful in the treatment or prevention of a disease characterized by beta-amyloid deposits in the brain (including, but not limited to, Alzheimer's Disease). The present invention also provides methods for preparing compounds of the invention.
申请公布号 US2004132782(A1) 申请公布日期 2004.07.08
申请号 US20030462127 申请日期 2003.06.16
申请人 YANG WENJIN;CARY DOUGLAS R.;JACOBS JEFFREY W.;LU WANLI;LU YAFAN;SUN JIAN;ZHONG MIN 发明人 YANG WENJIN;CARY DOUGLAS R.;JACOBS JEFFREY W.;LU WANLI;LU YAFAN;SUN JIAN;ZHONG MIN
分类号 C12N9/99;A61K31/166;A61K31/167;A61K38/00;A61P25/28;C07C231/12;C07C233/78;C07C235/50;C07C237/22;C07C271/54;C07C303/40;C07C311/08;C07C311/16;C07C311/21;C07C311/37;C07D207/08;C07D213/81;C07D213/82;C07D217/14;C07D241/08;C07D249/08;C07D263/32;C07D275/02;C07D277/30;C07D285/06;C07D285/10;C07D285/16;C07D285/18;C07D295/192;C07D307/54;C07D333/24;C07D333/38;C07D401/06;C07D409/06;C07K1/08;C07K5/027;C07K5/03;(IPC1-7):A61K31/44;A61K31/40;A61K31/165;A61K31/155 主分类号 C12N9/99
代理机构 代理人
主权项
地址